Viewing Study NCT00992758

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:08 AM
Ignite Modification Date: 2026-06-08 @ 4:44 PM
Study NCT ID: NCT00992758
Status: COMPLETED
Last Update Posted: 2017-07-25
First Post: 2009-10-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Non Hodgkin's Lymphoma (NHL) Patients With Greater Than 25% Bone Marrow Involvement
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma, Non-Hodgkin View
Keywords:

Keywords

Keyword Brief Keyword Text View
None bone marrow View
None Radioimmunotherapy View
None non-Hodgkin's lymphoma View
None Bexxar View
None anti-B1 antibody View
None tositumomab and iodine I-131 tositumomab View
None NHL View
None tositumomab View